They obviously were only interested in raising a quick $3M as it is clear they are carefully plodding along with small raises. They could throw this out to shareholders in a month or so if they need another chunk as a back up to having to do another Paulson raise. At least it clears out warrants while raising money.

Milestones are near as are licensing deals. Dilemma is a low SP to negotiate a deal and their unwillingness to lower the bar. IMO they are trying to make it to TNBC data, P3 Mono protocol, and BLA completion while sacrificing the least amount of equity.

BOD and management are very confident in the the strength of this molecule and what is highly probable to transpire in the second half of this year. If TNBC comes back mimicking the mouse models it’s going to be a helluva ride. If not Mono is still our ace in the hole. With both BP is going to come calling sooner than with just Mono.

The conundrum is money. That is the commodity that is standing between where we are now and the goal line. Quite the chess game going on and I’m feeling very bullish about our position.